Efficacy and tolerability of elagolix in adolescents and young adults with endometriosis: a small, single-center retrospective cohort study

Key Points

• Elagolix demonstrates significant efficacy for treating endometriosis-related symptoms in adolescents and young adults.
• Key metrics indicate that elagolix improved pain levels by more than 50% over a 3-month period.
• Retrospective cohort analysis utilized medical records from a single center over several years.
• Highlighting the need for additional studies on long-term effects and larger sample sizes.